Cardiac Rehabilitation Market By Product, By Disease Type, By End User : Global Opportunity Analysis and Industry Forecast, 2021-2031

List of Tables

The global cardiac rehabilitation market was valued at $1,971.1 million in 2021 and is projected to reach $3,241.38 million by 2031 registering a CAGR of 5.1% from 2022 to 2031.

Cardiac rehab is a medically supervised program which is designed to improve patient's cardiovascular health. It is customized outpatient program of exercise. Cardiac rehabilitation often involves exercise training to reduce heart disease risk. It is important for patients who are at higher risk of heart attack, heart failure, coronary artery bypass graft, and heart valve repair replacement. Cardiac rehabilitation program aims to limit the psychological stresses of cardiovascular disease and improve cardiovascular function to help patients achieve their highest quality of life possible. Cardiac rehab gives the information which is required in everyday life about heart disorders. These equipment/devices help recover from cardiovascular surgery and heart attack.

The main factors that foster the growth of the cardiac rehabilitation market are rise in cases of cardiovascular disease, and increase in adoption of tele-cardiac rehabilitation to minimize barriers for time, distance and cost. Along with this, a number of factors such as a large number of technological advancements in cardiac rehab devices, increase in adoption rate of these therapies, and rise in emphasis on early intervention and primary prevention of heart-related disorders are responsible for driving the market growth. Moreover, rise in demand and adoption of finger-tip oximeter devices during the COVID-19 pandemic for continuous patient monitoring and launch of new finger-tip pulse oximeter by large number of key players are the major factors driving the market growth. Furthermore, as per Organization for Economic Co-operation and Development, in 2018, a total of 45,307 cases of coronary artery bypass grafting procedures were performed in Germany. Hence, the surge in incidences of emergency surgeries and extensive uses of cardiac rehabilitation devices post-surgery propel the growth of the cardiac rehabilitation market.

Moreover, development of pharmaceutical & medical device industries and improvement in healthcare spending are anticipated to drive the growth of the cardiac rehabilitation market. For instance, in January 2020, Omron Corporation has launched HeartGuide device. This device is a wearable cardiac rehabilitation product that monitor blood pressure. It enabled people to monitor their blood pressure wherever and whenever they want. It also helps to understand the fluctuation of blood pressure in day time and helps to get control over high blood pressure. Regular self-monitoring of blood pressure can significantly reduce the risk of cardiac disorders. Moreover, high demand from the U.S. and pre-order availability for HeartGuide led Omron to file more than 80 patents to develop HeartGuide in the design of wrist watch that ensures the accuracy and reliability. Thus, presence of innovative product lines fuels the growth of the cardiac rehabilitation market.

Furthermore, rise in geriatric population and increase in burden of cardiovascular diseases lead to rise in awareness regarding cardiac rehabilitation among people, which drive the growth of the market. Moreover, according to World Health Organization, 17.9 million people were estimated to die from cardiovascular disease in 2019. Thus, upsurge in burden of cardiovascular diseases and increased rate of heart failure are anticipated to boost the demand for cardiac rehabilitation. Furthermore, rise in number of product approvals is expected to provide remunerative opportunities for the expansion of the global market during the forecast period. Sedentary lifestyle makes people susceptible to having many disorders such as diabetes, and cardiovascular disorders. High blood pressure and diabetes are the two main factors responsible for the rise in number of heart failures. This disease is associated with high hospitalization rate and substantial cost due to frequent use of heart rate and blood pressure monitor devices. Thus, an increase in number of surgeries due to rise in cases of chronic diseases is expected to increase the adoption rate of cardiac rehabilitation products and increase the growth of the market.

However, high costs of cardiac rehabilitation products, limited availability of funds, and dearth of skilled professionals are the factors projected to impede the market growth. Presently, there is an increase in awareness regarding health among people, which, in turn, compels them to maintain their health condition and leads to rise in usage of home fitness devices. This has encouraged many key players to enter emerging market, thus offering lucrative growth opportunities in the cardiac rehabilitation market.

For the purpose of analysis cardiac rehabilitation market is studied across by product type, disease type, and end user. On the basis of product type the market is segmented into elliptical trainer, stabilization ball, treadmills, heart rate monitor, blood pressure monitor, rower, and others. By disease type, the market is divided into percutaneous coronary intervention, myocardial infraction, coronary artery bypass grafting, coronary artery disease, and others. By end user, it is categorized into rehab centers, hospitals, clinics, and others. By region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The key players mentioned in the report are Baxter International Inc., Core Health & Fitness, LLC, GE Healthcare, Halma Plc, Johnson Health Tech, Koninklijke Philips N.V, Life Fitness, Omron Corporation, Smith Group, and Technogym.

Key Benefits For Stakeholders

This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the cardiac rehabilitation market analysis from 2021 to 2031 to identify the prevailing cardiac rehabilitation market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the cardiac rehabilitation market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global cardiac rehabilitation market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Product

Elliptical Trainer
Stabilization ball
Treadmill
Heart rate monitor
Blood pressure monitor
Rower
Others

By Disease Type

Percutaneous Coronary Intervention
Myocardial Infarction
Coronary Artery Bypass Grafting
Coronary Artery Disease
Others

By End User

Rehab Centers
Hospitals
Clinics
Others

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Rest of Europe
Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Rest of Asia-Pacific
LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
Key Market Players
- Halma plc.
- Life Fitness
- GE Healthcare
- Smiths Group
- Koninklijke Philips N.V.
- Omron Corporation
- Technogym
- Core Health & Fitness, LLC
- Baxter
- Johnson Health Tech.

Product Code: A11270

CHAPTER 1:INTRODUCTION

1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
- 1.4.1.Secondary research
- 1.4.2.Primary research
- 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key findings of the study
2.2.CXO Perspective

CHAPTER 3:MARKET OVERVIEW

3.1.Market definition and scope
3.2.Key findings
- 3.2.1.Top investment pockets
3.3.Porter's five forces analysis
3.4.Top player positioning
3.5.Market dynamics
- 3.5.1.Drivers
- 3.5.2.Restraints
- 3.5.3.Opportunities
3.6.COVID-19 Impact Analysis on the market

CHAPTER 4: CARDIAC REHABILITATION MARKET, BY PRODUCT

4.1 Overview
- 4.1.1 Market size and forecast
4.2 Elliptical Trainer
- 4.2.1 Key market trends, growth factors and opportunities
- 4.2.2 Market size and forecast, by region
- 4.2.3 Market analysis by country
4.3 Stabilization ball
- 4.3.1 Key market trends, growth factors and opportunities
- 4.3.2 Market size and forecast, by region
- 4.3.3 Market analysis by country
4.4 Treadmill
- 4.4.1 Key market trends, growth factors and opportunities
- 4.4.2 Market size and forecast, by region
- 4.4.3 Market analysis by country
4.5 Heart rate monitor
- 4.5.1 Key market trends, growth factors and opportunities
- 4.5.2 Market size and forecast, by region
- 4.5.3 Market analysis by country
4.6 Blood pressure monitor
- 4.6.1 Key market trends, growth factors and opportunities
- 4.6.2 Market size and forecast, by region
- 4.6.3 Market analysis by country
4.7 Rower
- 4.7.1 Key market trends, growth factors and opportunities
- 4.7.2 Market size and forecast, by region
- 4.7.3 Market analysis by country
4.8 Others
- 4.8.1 Key market trends, growth factors and opportunities
- 4.8.2 Market size and forecast, by region
- 4.8.3 Market analysis by country

CHAPTER 5: CARDIAC REHABILITATION MARKET, BY DISEASE TYPE

5.1 Overview
- 5.1.1 Market size and forecast
5.2 Percutaneous Coronary Intervention
- 5.2.1 Key market trends, growth factors and opportunities
- 5.2.2 Market size and forecast, by region
- 5.2.3 Market analysis by country
5.3 Myocardial Infarction
- 5.3.1 Key market trends, growth factors and opportunities
- 5.3.2 Market size and forecast, by region
- 5.3.3 Market analysis by country
5.4 Coronary Artery Bypass Grafting
- 5.4.1 Key market trends, growth factors and opportunities
- 5.4.2 Market size and forecast, by region
- 5.4.3 Market analysis by country
5.5 Coronary Artery Disease
- 5.5.1 Key market trends, growth factors and opportunities
- 5.5.2 Market size and forecast, by region
- 5.5.3 Market analysis by country
5.6 Others
- 5.6.1 Key market trends, growth factors and opportunities
- 5.6.2 Market size and forecast, by region
- 5.6.3 Market analysis by country

CHAPTER 6: CARDIAC REHABILITATION MARKET, BY END USER

6.1 Overview
- 6.1.1 Market size and forecast
6.2 Rehab Centers
- 6.2.1 Key market trends, growth factors and opportunities
- 6.2.2 Market size and forecast, by region
- 6.2.3 Market analysis by country
6.3 Hospitals
- 6.3.1 Key market trends, growth factors and opportunities
- 6.3.2 Market size and forecast, by region
- 6.3.3 Market analysis by country
6.4 Clinics
- 6.4.1 Key market trends, growth factors and opportunities
- 6.4.2 Market size and forecast, by region
- 6.4.3 Market analysis by country
6.5 Others
- 6.5.1 Key market trends, growth factors and opportunities
- 6.5.2 Market size and forecast, by region
- 6.5.3 Market analysis by country

CHAPTER 7: CARDIAC REHABILITATION MARKET, BY REGION

7.1 Overview
- 7.1.1 Market size and forecast
7.2 North America
- 7.2.1 Key trends and opportunities
- 7.2.2 North America Market size and forecast, by Product
- 7.2.3 North America Market size and forecast, by Disease Type
- 7.2.4 North America Market size and forecast, by End User
- 7.2.5 North America Market size and forecast, by country
  - 7.2.5.1 U.S.
  - 7.2.5.1.1 Market size and forecast, by Product
  - 7.2.5.1.2 Market size and forecast, by Disease Type
  - 7.2.5.1.3 Market size and forecast, by End User
  - 7.2.5.2 Canada
  - 7.2.5.2.1 Market size and forecast, by Product
  - 7.2.5.2.2 Market size and forecast, by Disease Type
  - 7.2.5.2.3 Market size and forecast, by End User
  - 7.2.5.3 Mexico
  - 7.2.5.3.1 Market size and forecast, by Product
  - 7.2.5.3.2 Market size and forecast, by Disease Type
  - 7.2.5.3.3 Market size and forecast, by End User
7.3 Europe
- 7.3.1 Key trends and opportunities
- 7.3.2 Europe Market size and forecast, by Product
- 7.3.3 Europe Market size and forecast, by Disease Type
- 7.3.4 Europe Market size and forecast, by End User
- 7.3.5 Europe Market size and forecast, by country
  - 7.3.5.1 Germany
  - 7.3.5.1.1 Market size and forecast, by Product
  - 7.3.5.1.2 Market size and forecast, by Disease Type
  - 7.3.5.1.3 Market size and forecast, by End User
  - 7.3.5.2 France
  - 7.3.5.2.1 Market size and forecast, by Product
  - 7.3.5.2.2 Market size and forecast, by Disease Type
  - 7.3.5.2.3 Market size and forecast, by End User
  - 7.3.5.3 U.K.
  - 7.3.5.3.1 Market size and forecast, by Product
  - 7.3.5.3.2 Market size and forecast, by Disease Type
  - 7.3.5.3.3 Market size and forecast, by End User
  - 7.3.5.4 Italy
  - 7.3.5.4.1 Market size and forecast, by Product
  - 7.3.5.4.2 Market size and forecast, by Disease Type
  - 7.3.5.4.3 Market size and forecast, by End User
  - 7.3.5.5 Spain
  - 7.3.5.5.1 Market size and forecast, by Product
  - 7.3.5.5.2 Market size and forecast, by Disease Type
  - 7.3.5.5.3 Market size and forecast, by End User
  - 7.3.5.6 Rest of Europe
  - 7.3.5.6.1 Market size and forecast, by Product
  - 7.3.5.6.2 Market size and forecast, by Disease Type
  - 7.3.5.6.3 Market size and forecast, by End User
7.4 Asia-Pacific
- 7.4.1 Key trends and opportunities
- 7.4.2 Asia-Pacific Market size and forecast, by Product
- 7.4.3 Asia-Pacific Market size and forecast, by Disease Type
- 7.4.4 Asia-Pacific Market size and forecast, by End User
- 7.4.5 Asia-Pacific Market size and forecast, by country
  - 7.4.5.1 Japan
  - 7.4.5.1.1 Market size and forecast, by Product
  - 7.4.5.1.2 Market size and forecast, by Disease Type
  - 7.4.5.1.3 Market size and forecast, by End User
  - 7.4.5.2 China
  - 7.4.5.2.1 Market size and forecast, by Product
  - 7.4.5.2.2 Market size and forecast, by Disease Type
  - 7.4.5.2.3 Market size and forecast, by End User
  - 7.4.5.3 Australia
  - 7.4.5.3.1 Market size and forecast, by Product
  - 7.4.5.3.2 Market size and forecast, by Disease Type
  - 7.4.5.3.3 Market size and forecast, by End User
  - 7.4.5.4 India
  - 7.4.5.4.1 Market size and forecast, by Product
  - 7.4.5.4.2 Market size and forecast, by Disease Type
  - 7.4.5.4.3 Market size and forecast, by End User
  - 7.4.5.5 South Korea
  - 7.4.5.5.1 Market size and forecast, by Product
  - 7.4.5.5.2 Market size and forecast, by Disease Type
  - 7.4.5.5.3 Market size and forecast, by End User
  - 7.4.5.6 Rest of Asia-Pacific
  - 7.4.5.6.1 Market size and forecast, by Product
  - 7.4.5.6.2 Market size and forecast, by Disease Type
  - 7.4.5.6.3 Market size and forecast, by End User
7.5 LAMEA
- 7.5.1 Key trends and opportunities
- 7.5.2 LAMEA Market size and forecast, by Product
- 7.5.3 LAMEA Market size and forecast, by Disease Type
- 7.5.4 LAMEA Market size and forecast, by End User
- 7.5.5 LAMEA Market size and forecast, by country
  - 7.5.5.1 Brazil
  - 7.5.5.1.1 Market size and forecast, by Product
  - 7.5.5.1.2 Market size and forecast, by Disease Type
  - 7.5.5.1.3 Market size and forecast, by End User
  - 7.5.5.2 Saudi Arabia
  - 7.5.5.2.1 Market size and forecast, by Product
  - 7.5.5.2.2 Market size and forecast, by Disease Type
  - 7.5.5.2.3 Market size and forecast, by End User
  - 7.5.5.3 South Africa
  - 7.5.5.3.1 Market size and forecast, by Product
  - 7.5.5.3.2 Market size and forecast, by Disease Type
  - 7.5.5.3.3 Market size and forecast, by End User
  - 7.5.5.4 Rest of LAMEA
  - 7.5.5.4.1 Market size and forecast, by Product
  - 7.5.5.4.2 Market size and forecast, by Disease Type
  - 7.5.5.4.3 Market size and forecast, by End User

CHAPTER 8: COMPANY LANDSCAPE

8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Key developments

CHAPTER 9: COMPANY PROFILES

9.1 Halma plc.
- 9.1.1 Company overview
- 9.1.2 Company snapshot
- 9.1.3 Operating business segments
- 9.1.4 Product portfolio
- 9.1.5 Business performance
- 9.1.6 Key strategic moves and developments
9.2 Life Fitness
- 9.2.1 Company overview
- 9.2.2 Company snapshot
- 9.2.3 Operating business segments
- 9.2.4 Product portfolio
- 9.2.5 Business performance
- 9.2.6 Key strategic moves and developments
9.3 GE Healthcare
- 9.3.1 Company overview
- 9.3.2 Company snapshot
- 9.3.3 Operating business segments
- 9.3.4 Product portfolio
- 9.3.5 Business performance
- 9.3.6 Key strategic moves and developments
9.4 Smiths Group
- 9.4.1 Company overview
- 9.4.2 Company snapshot
- 9.4.3 Operating business segments
- 9.4.4 Product portfolio
- 9.4.5 Business performance
- 9.4.6 Key strategic moves and developments
9.5 Koninklijke Philips N.V.
- 9.5.1 Company overview
- 9.5.2 Company snapshot
- 9.5.3 Operating business segments
- 9.5.4 Product portfolio
- 9.5.5 Business performance
- 9.5.6 Key strategic moves and developments
9.6 Omron Corporation
- 9.6.1 Company overview
- 9.6.2 Company snapshot
- 9.6.3 Operating business segments
- 9.6.4 Product portfolio
- 9.6.5 Business performance
- 9.6.6 Key strategic moves and developments
9.7 Technogym
- 9.7.1 Company overview
- 9.7.2 Company snapshot
- 9.7.3 Operating business segments
- 9.7.4 Product portfolio
- 9.7.5 Business performance
- 9.7.6 Key strategic moves and developments
9.8 Core Health & Fitness, LLC
- 9.8.1 Company overview
- 9.8.2 Company snapshot
- 9.8.3 Operating business segments
- 9.8.4 Product portfolio
- 9.8.5 Business performance
- 9.8.6 Key strategic moves and developments
9.9 Baxter
- 9.9.1 Company overview
- 9.9.2 Company snapshot
- 9.9.3 Operating business segments
- 9.9.4 Product portfolio
- 9.9.5 Business performance
- 9.9.6 Key strategic moves and developments
9.10 Johnson Health Tech.
- 9.10.1 Company overview
- 9.10.2 Company snapshot
- 9.10.3 Operating business segments
- 9.10.4 Product portfolio
- 9.10.5 Business performance
- 9.10.6 Key strategic moves and developments